| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | YY INC | 19,000 | 749,000 | 0.02% | ||
| 152 | REGENERON PHARMACEUTICALS | 2,000 | 734,000 | 0.02% | ||
| 153 | ANTHEM INC | 4,500 | 647,000 | 0.02% | ||
| 154 | PRAXAIR INC | 4,000 | 469,000 | 0.01% | ||
| 155 | CASCADIAN THERAPEUTICS INC | 84,000 | 362,000 | 0.01% | ||
| 156 | CANADIAN SOLAR INC | 28,600 | 348,000 | 0.01% | ||
| 157 | SUNPOWER CORP | 29,870 | 197,000 | 0.01% | ||
| 158 | OBALON THERAPEUTICS INC | 20,000 | 177,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001398318-17-000002, filed 2017.02.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
